Healthy and Beauty Synergies: MEDIROM Healthcare Technologies and SBC Medical Group Holdings Announce Business Alliance
MEDIROM Healthcare Technologies (NASDAQ: MRM) has announced a strategic business alliance with SBC Medical Group Holdings. The partnership combines MEDIROM's Re.Ra.Ku wellness salon, which primarily serves male customers, with SBC's Shonan Beauty Clinic, which focuses on women in their 20s and 30s. Together, the companies have over 4 million loyalty program members.
The alliance aims to create integrated opportunities for their respective customer bases, with plans to distribute special invitation tickets across their locations. MEDIROM operates over 300 wellness salons across Japan, while SBC Medical provides management services to 224 franchisees worldwide, including locations in Vietnam and California.
MEDIROM Healthcare Technologies (NASDAQ: MRM) ha annunciato un'alleanza strategica con SBC Medical Group Holdings. Questa partnership unisce il salone di benessere Re.Ra.Ku di MEDIROM, che serve principalmente clienti maschili, con la Shonan Beauty Clinic di SBC, che si concentra su donne negli anni '20 e '30. Insieme, le aziende vantano oltre 4 milioni di membri del programma di fidelizzazione.
L'alleanza mira a creare opportunità integrate per le rispettive basi di clienti, con piani per distribuire biglietti di invito speciali nei loro punti vendita. MEDIROM gestisce oltre 300 saloni di benessere in Giappone, mentre SBC Medical fornisce servizi di gestione a 224 affiliati in tutto il mondo, compresi i luoghi in Vietnam e California.
MEDIROM Healthcare Technologies (NASDAQ: MRM) ha anunciado una alianza comercial estratégica con SBC Medical Group Holdings. La asociación combina el salón de bienestar Re.Ra.Ku de MEDIROM, que atiende principalmente a clientes masculinos, con la Shonan Beauty Clinic de SBC, que se centra en mujeres de sus 20 y 30 años. Juntas, las empresas cuentan con más de 4 millones de miembros en su programa de lealtad.
La alianza tiene como objetivo crear oportunidades integradas para sus respectivas bases de clientes, con planes para distribuir boletos de invitación especiales en sus ubicaciones. MEDIROM opera más de 300 salones de bienestar en Japón, mientras que SBC Medical proporciona servicios de gestión a 224 franquiciados en todo el mundo, incluidos lugares en Vietnam y California.
MEDIROM Healthcare Technologies (NASDAQ: MRM)은 SBC Medical Group Holdings와 전략적 사업 제휴를 발표했습니다. 이 파트너십은 남성 고객을 주로 대상으로 하는 MEDIROM의 Re.Ra.Ku 웰니스 살롱과 20대와 30대 여성에 중점을 둔 SBC의 Shonan Beauty Clinic을 결합합니다. 두 회사는 함께 400만 명 이상의 충성도 프로그램 회원을 보유하고 있습니다.
이 제휴의 목표는 각 고객 기반에 대한 통합된 기회를 창출하는 것으로, 각 지점에서 특별 초대권을 배포할 계획이 있습니다. MEDIROM은 일본 전역에 300개 이상의 웰니스 살롱을 운영하며, SBC Medical은 베트남과 캘리포니아를 포함하여 전 세계 224개의 프랜차이즈에 관리 서비스를 제공합니다.
MEDIROM Healthcare Technologies (NASDAQ: MRM) a annoncé une alliance commerciale stratégique avec SBC Medical Group Holdings. Ce partenariat combine le salon de bien-être Re.Ra.Ku de MEDIROM, qui s'adresse principalement à une clientèle masculine, avec la Shonan Beauty Clinic de SBC, qui se concentre sur les femmes dans la vingtaine et la trentaine. Ensemble, les entreprises comptent plus de 4 millions de membres dans leur programme de fidélité.
L'alliance vise à créer des opportunités intégrées pour leurs bases de clients respectives, avec des plans pour distribuer des billets d'invitation spéciaux dans leurs établissements. MEDIROM exploite plus de 300 salons de bien-être à travers le Japon, tandis que SBC Medical fournit des services de gestion à 224 franchisés dans le monde entier, y compris des établissements au Vietnam et en Californie.
MEDIROM Healthcare Technologies (NASDAQ: MRM) hat eine strategische Geschäftspartnerschaft mit SBC Medical Group Holdings angekündigt. Die Partnerschaft vereint MEDIROMs Re.Ra.Ku Wellness-Salon, der hauptsächlich männliche Kunden bedient, mit der Shonan Beauty Clinic von SBC, die sich auf Frauen in ihren 20ern und 30ern konzentriert. Gemeinsam verfügen die Unternehmen über 4 Millionen Mitglieder im Treueprogramm.
Das Ziel der Allianz ist es, integrierte Möglichkeiten für ihre jeweiligen Kundenbasen zu schaffen, wobei Pläne bestehen, spezielle Einladungskarten an ihren Standorten zu verteilen. MEDIROM betreibt mehr als 300 Wellness-Salons in Japan, während SBC Medical Management-Dienstleistungen für 224 Franchisenehmer weltweit anbietet, einschließlich Standorten in Vietnam und Kalifornien.
- Access to combined loyalty program with 4 million members
- Market expansion through complementary customer demographics
- Potential revenue growth through cross-selling opportunities
- Geographic expansion potential through SBC's international presence
- None.
Insights
This business alliance between MEDIROM and SBC Medical represents a strategic move to tap into complementary market segments. The combined loyalty program base of 4 million members presents significant cross-selling opportunities. MEDIROM's male-focused Re.Ra.Ku wellness salons and SBC's female-centric Shonan Beauty Clinic create minimal cannibalization risk while maximizing market expansion potential.
The partnership could drive revenue growth through customer base diversification and enhanced service offerings. However, execution risks exist in integrating different customer experiences and maintaining brand identity. With MEDIROM's market cap of
TOKYO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announced a business alliance with SBC Medical Group Holdings Incorporated (Nasdaq: SBC) a global owner, operator and provider of management services and products to cosmetic treatment centers.
Our two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC’s “Shonan Beauty Clinic” and MEDIROM’s “Re.Ra.Ku wellness salon”. In addition to bringing customers enhanced offerings and expertise, the alliance will seek to create compelling, integrated opportunities to harness the power of these loyal customers and reward them when they receive services at SBC Medical and MEDIROM.
In this alliance, both companies have elevated expectations for their different customer segments. Shonan Beauty Clinic is widely supported mainly by women in their 20s and 30s, while MEDIROM’s Re.Ra.Ku serves mainly male customers for relaxation and health maintenance. This collaboration is expected to enable the two companies to approach new markets, expand total customer base, and provide new value.
“We believe we can provide new value and ’Healthy and Beauty Synergies’ by distributing special invitation tickets to customers visiting each store,” said Kouji Eguchi, CEO, MEDIROM.
About SBC Medical
SBC Medical, through its subsidiaries, provides services to support the operation of clinics that deliver highly specialized medical services in the areas of cosmetic medicine, esthetic dentistry, and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical and its subsidiaries now provide management services to a total of 224 franchisees located worldwide. For Global, SBC Medical owns and operates one treatment center in Vietnam and provides management services to one treatment center in State of California in the United States. For more information, visit https://sbc-holdings.com/
Contact:
SBC Medical Group Holdings Incorporated
Hikaru Fukui / Head of Investor Relations
E-mail: ir@sbc-holdings.com
About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates over 300 wellness salons across Japan, Re.Ra.Ku® being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business and launched new healthcare programs using an on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. In 2023, MEDIROM launched REMONY, a remote monitoring system for corporate clients, and has received orders from a broad range of industries, including nursing care, transportation, construction, and manufacturing, among others. MEDIROM hopes that its diverse health-related product and service offerings will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en.
Contact:
Investor Relations Team
E-mail:ir@medirom.co.jp
Forward-Looking Statements Regarding MEDIROM
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:
- MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives;
- MEDIROM’s and SBC Medical Group’s ability to collaborate in the anticipated manner;
- changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets;
- MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment;
- the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies;
- MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property;
- MEDIROM’s ability to raise additional capital on acceptable terms or at all;
- MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments;
- changes in consumer preferences and MEDIROM’s competitive environment;
- MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and
- the regulatory environment in which MEDIROM operates.
More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.
FAQ
What is the purpose of MEDIROM's (MRM) alliance with SBC Medical Group?
How many locations does MEDIROM (MRM) operate as of November 2023?
What is the target demographic difference between MEDIROM (MRM) and SBC Medical?
